Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
HC Wainwright & Co. analyst Ed Arce upgrades Synlogic (NASDAQ:SYBX) from Sell to Neutral.
Synlogic (NASDAQ:SYBX) reported quarterly losses of $(1.71) per share which missed the analyst consensus estimate of $(0.97) by...
Synlogic, Inc. (NASDAQ:SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious disease...
Synlogic shares are trading lower by 48.4% to $1.78 Friday afternoon. The company announced it will discontinue Synpheny-3, cea...
U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 1% on Friday. The Dow trade...
Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter res...
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 100 points on Friday. The Dow traded d...
